An Austrian doctor who prescribes abortion drugs to patients around the world is suing the United States for allegedly blocking her American patients from getting abortions by seizing their prescriptions.
Dr. Rebecca Gomperts filed the lawsuit in U.S. District Court in Idaho on Monday, asking a judge to stop the Food and Drug Administration from taking any steps that would prevent her patients from accessing the abortion-inducing drugs.
"For many women seeking to terminate their unwanted pregnancies prior to viability, the only practical option is found on the internet," Gomperts and her attorney Richard Hearn wrote in the lawsuit.
In many rural states, abortion providers are few and far between, Hearn said on Monday. That limits abortion access to women with the money and means to travel, or to those who can find a provider on the internet such as Gomperts.
One of Gomperts' first patients was a 14-year-old girl, Hearn said.
"How many 14-year-olds can rent a car, drive down secretly to Salt Lake City or Boise, and then spend the night there and take these pills and go to a follow-up appointment and then go home? Practically, it's just not available to poor people in states like Idaho," Hearn said.
Women seeking abortions generally have two options: A surgical abortion where the embryo or fetus is physically removed from the womb or a medication abortion where medications are essentially used to induce a miscarriage in the first few weeks of a pregnancy.
The drugs typically used for a medication abortion, misoprostol and mifepristone, are highly regulated by the FDA and doctors in the U.S. must have a specialty license to prescribe them.
Gomperts, who splits her time between homes in Wien, Austria, and Amsterdam, the Netherlands, started an organization called Aid Access to serve women seeking first-trimester abortions in early 2018.
She prescribes the abortion-inducing medications through the Aid Access website, and then the organization gives the women information on how to fill their prescriptions using a merchant prescription drug exporter based in India. India's laws allow the exporter to legally export small quantities of drugs for a patient's personal use.
More than 40,000 women have contacted Aid Access since the organization began, according to the lawsuit, including roughly 37,000 women from the United States.
Of those, Gomperts has prescribed the abortion-inducing drugs to more than 7,000, including roughly 40 women in Idaho, where the lawsuit was filed.
The FDA sent Gomperts a letter in March warning her that the agency believed she was violating federal law by "introducing into interstate commerce misbranded and unapproved new drugs."
"It's a stupid idea, but if you want to block drugs like insulin, that's OK," Hearn said. "But if you block a woman -- or a 14- or 15-year-old girl -- who only has a couple of weeks when she can take these pills and you seize them?
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
